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Background/aim: Natural products are popular insights for researchers to investigate promising anti-cancer agents since some of these
substances have lesser adverse effects restricting the treatment than traditional chemotherapeutic agents. A well-known monoterpene
Carvacrol, widely consumed in Mediterranean cuisine and lower risks of cancer, has efficient anticancer effects. However, the mechanism
of action is yet to be discovered.
Materials and methods: The investigation aims to illuminate a new perceptive in the role of this substance on colorectal cancer
treatment, by the means of differences in a well-defined range of soluble factors. Carvacrol effect on both HT-29 and HCT-116 cell
lines was evaluated on proliferation and the IC50 values were calculated by the RTCA xCELLigence device. Then MAGPIX assay was
performed to obtain the changes in soluble factors of the cell lines.
Results: The Multiplexing assay suggests some of these factors were altered in favor of surviving and proliferation in aggressive cell line
HCT-116 whereas they were altered against these characters in HT-29, were correlated with the increased IC50 concentration of HCT116 in carvacrol treatment.
Conclusion: The current study indicates that differences in the levels of these soluble factors could modulate the anticancer effect related
to carvacrol.
Key words: Carvacrol, phytochemical, colon cancer, soluble factors

1. Introduction
Colon cancer has become a major public health issue with
1,849,518 new cases in 2018. 10.2% of all cancer deaths in the
same year were caused by this malign disease which brings
it to the second rank in cancer related deaths [1]. Several
factors (i.e. age, familial cancer syndromes, inflammatory
bowel disease, dietary factors, hereditary polyposis
conditions) affect the development of this malignancy
[2]. Nowadays, the most accepted therapies are surgery,
radiotherapy, and chemotherapy such as 5-fluorouracil
and oxaliplatin [3,4]. However, all these procedures have
their own difficulties, the adverse effects related to systemic
chemotherapy are much restrictive due to their mortality.
Since some of the natural products as chemotherapeutic
agents indicate lower side effects on patients, they are
promising anticancer agents and safer sources of cancer
treatments. Moreover, such phytochemicals are also

related with chemopreventive agents because of their
eﬀiciency and low toxicity. Therefore, the scientists
focus on evaluating phytochemicals with multitargeted
potentials for eﬀective chemoprevention [5].
Terpenes (C10H16) illustrated enormous effectiveness
as chemopreventive agent in the last years however
the mechanism of action is not clear yet (a subclass
of this family, terpenoids, has been characterized
as monoterpenes, diterpenes, oligoterpenes, and
polyterpenes). They involve roughly 25,000 chemical
structures which are used in pharmaceutical industries [6].
Carvacrol is also a member of this family. The substance
presents in various sources that are extensively tested
with enormous biological activities [7]. Mediterraneans
regularly consume this product with oregano spice that
presents a lesser risk of colorectal cancer compared to
the other local cuisines [8]. Nowadays, it is well-known
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that the carvacrol in this spice is the one reason that the
substance has preventive properties. It basically protects
mammalian cells against DNA strand breaks along with
rosmarinic acid [9,10]. Moreover, several studies point out
that carvacrol illustrates further anticancer effects such as
genotoxic, cytotoxic, and proapoptotic activity to cancer
cells, in a dose-dependent manner. Additionally, it has
also an important preventive role in cell invasion by down
regulating of matrix metalloprotease 2 and 9 expressions
[11].
Tumor microenvironments involve various cell types
and extracellular matrix substances in the niche of cancer
such as soluble factors. The soluble factors which could be
related to cell proliferation are granulocyte-macrophage
colony-stimulating factor (GM-CSF), leptin, prolactin
and soluble vascular endothelial growth factor receptor-2
(sVEGFR2) evaluated [12]. Prolactin may involve in
the genetic and molecular mechanisms for regulating
the proliferation and growth of neoplastic and normal
epithelial cells in the gastrointestinal tract [13]. Moreover,
leptin is crucial for colorectal cancer (CRC) growth in
obese patients [14]. On the other hand, sVEGFR2 involves
the extracellular domains of the receptor but lacks the
tyrosine kinase domain [15]. GM-CSF has an important
role in hematopoiesis and immune modulation. GM-CSF
also stimulates the progression of immune-independent
tumors by inducing tumor growth, metastasis, and
promoting tumor microenvironments. Hence several
studies suggest that this factor triggers some effects on
tumor progression [16].
Since these soluble factors manage the tumor
microenvironment and the behavior of cancer as
mentioned previously, the present study investigates the
changes in these soluble factors when HT-29 and HCT116 colorectal adenocarcinoma cell lines are treated with
carvacrol in a dose-dependent manner. We suggest that
the results could lead us one step further to discover the
mechanism of action of carvacrol through the soluble
factors.
2. Materials and methods
2.1. Cell culture
Human colorectal carcinoma, HCT-116 (ATCC CCL247) and HT-29 (ATCC HTB-38) cell lines were
purchased from American Type Culture Collection
(ATCC) (Rockville, CT, USA). They were cultured in
McCoy’s-5a modified medium (BiochromGbmH, Berlin,
Germany) supplemented with 1% penicillin/streptomycin
(BiochromGbmH, Berlin, Germany) and 10% fetal bovine
serum (FBS, Cegrogen Biotech GmbH, Stadtallendorf,
Germany). Cells were incubated at 37 °C in a humidified
5% CO2 incubator.
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2.2. Cell viability
The antiproliferative effect of carvacrol (C7727, SigmaAldrich, St Louis, MO, USA) has been studied on HCT116 and HT-29 colorectal adenocarcinoma cell lines.
The cell lines were seeded in a triplicate in 96-well plate
(10,000 cells per well). Cell viability was tested after 48 h
of incubation with 25–200 µM carvacrol via xCELLigence
real-time cell analysis instrument (ACEA Biosciences, Inc
(ACEA), San Diego, California, USA).
2.3. Analysis of soluble factors via multiplexing assay
Colorectal adenocarcinoma cell lines, HCT-116, and HT29 were treated with carvacrol at IC50 values individually.
Both carvacrol treated and nontreated control groups were
seeded into wells and run in triplicate. The fluorescent signal
was measured by a CCD imager and the concentrations
of the analytes were determined by MAGPIX xPONENT
software. The results were normalized to total protein
concentration estimated with Bradford assay.
2.4. Statistical analysis
SPSS version 24.0 (IBM Corp., Armonk, NY, USA) was used
for all analyses. Willcoxon signed ranks nonparametric
test was used to determine the significance between the
application of different doses of carvacrol on different cell
lines individually and its control group. The data in the
Figure are represented as the mean ± standard error of the
mean. In the study, all tests were performed in triplicate.
The level of statistical significance was set at P < 0.05 .
3. Results
The current investigation draws attention to the carvacrol
effect in proliferation and also points out its mechanism of
action through the alterations in the level of soluble factors
in colorectal cancer cell lines with different phenotypes.
The methodology indicates the IC50 values for carvacrol
and follows through the MAGPIX multiplexing assay to
illuminate the changes in soluble factors in response to
IC50 values of carvacrol on HCT-116 and HT-29 colorectal
cancer cell lines.
3.1. The effect of carvacrol on cell proliferation of colorectal cancer cells
The in vitro proliferation activity doses of carvacrol on
HCT-116 and HT-29 cell lines were measured by using the
xCELLigence real-time cell analysis instrument. After 48
h of incubation with carvacrol, IC50 values were found as
92 µM for HCT-116 and 42 µM for HT-29 cell lines. The
results are illustrated in Figure.
3.2. Carvacrol effect on soluble factors in colon cancer
cell lines with different phenotypes
The soluble factors were analyzed to evaluate the cellular
response leading to cytotoxicity in both cell lines and the
difference between the response intensity to carvacrol.
The measurements in samples were achieved by MAGPIX
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Figure. The antiproliferation effect of carvacrol in colorectal cancer. Dose-dependent
cytotoxicity activity of carvacrol on HT-29 (A). The HCT-116 cell line was incubated
with increasing concentrations of curcumin (B). After 48 h of incubation at 37 °C
and 5% CO2 the cell viability was measured by xCELLigence real-time cell analysis
instrument.

multiplexing assay. The Table which shows the normalized
data illuminates that the secretion of several soluble
factors related to growth and survival such as prolactin,
leptin, and GM-CSF were increased in carvacrol treated
HCT-116 while they were decreased in carvacrol treated
HT-29 comparing to nontreated control groups. Prolactin,
leptin, and GM-CSF concentrations were measured as
57.5, 9, and 82 pg/mL in HCT-116 and, 147, 17.74, and 104
pg/mL in HT-29 with no carvacrol concentration. These
values raised in concentration to 117, 23, 105 pg/mL (P
= 0.028 for all concentrations), in response to 92 µM and
the IC50 value of carvacrol, respectively. However, they
decreased to 53.49, 14.49, and 96 pg/mL concentrations
(P = 0.028 for all concentrations) compared to the control

concentrations in HT-29 treated with 42 µM of the phytocompound. However, proliferative and survival factor
TGF-α decreased in both cell lines, correlated with earlier
proliferation assay. This factor was estimated as 67 pg/mL
for HCT-116 and 106.2 pg/mL for HT-29. Both values
diminished where the concentration for HCT-116 treated
with 92 µM substance was 24 pg/mL (P = 0.028) and 26 pg/
mL (P = 0.109) for HT-29 treated with 42 µM of carvacrol.
4. Discussion
The present study focused on the effect of carvacrol
in proliferation and also illuminated its mechanism of
action through the change in the level of soluble factors
in colorectal cancer cell lines with different phenotypes.
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Table. Statistically significant concentration levels of soluble factors in carvacrol treated samples compared to
nontreated controls. All measurements were achieved by MAGPIX multiplexing assay. Red indicates a decrease
whereas green illustrates an increase in concentrations compared to controls.
Groups

HT-29

HCT-116

Soluble factors

Control (pg/mL)

Treated (pg/mL)

P- value

Evaluation

GMCSF

104.0000

96.0000

0.028

decreased

FGF basic

55.4967

41.2467

0.028

decreased

GCSF

177.9967

116.7200

0.028

decreased

HGF

35.7567

27.9967

0.028

decreased

Leptin

17.7467

14.4967

0.028

decreased

Osteopontin

49.5000

61.6200

0.028

increased

PECAM1

72.7467

77.9967

0.028

increased

Prolactin

147.0000

53.4967

0.028

decreased

SCF

29.7467

46.2467

0.028

increased

sEGFR

57.9967

41.4967

0.028

decreased

sHER2neu

35.2467

22.9967

0.028

decreased

sIL6Ra

36.9967

12.4967

0.028

decreased

sTIE2

45.2467

44.0000

0.028

decreased

sVEGFR1

77.9967

10.4967

0.028

decreased

sVEGFR2

30.4967

14.9967

0.028

decreased

IL18

30.0000

19.4967

0.028

decreased

TGF

106.2467

25.9967

0.109

decreased

VEGFC

16.9967

40.9967

0.002

increased

GMCSF

82.0000

105.0000

0.028

increased

IL8

30.0000

9.0000

0.028

decreased

FGF basic

22.4967

47.9967

0.028

increased

GCSF

116.2467

117.4967

0.028

increased

HGF

12.5000

15.0000

0.028

increased

Leptin

8.9967

23.4967

0.028

increased

Osteopontin

40.9933

53.5000

0.028

increased

PECAM1

16.4967

27.9967

0.028

increased

Prolactin

57.4967

117.0000

0.028

increased

SCF

44.7467

61.9967

0.028

increased

sHER2neu

28.2467

78.2467

0.028

increased

sIL6Ra

23.9967

27.4967

0.028

increased

sTIE2

39.2467

34.0000

0.028

decreased

sVEGFR1

72.2467

66.4967

0.028

decreased

sVEGFR2

10.0000

21.9967

0.028

increased

TGF

66.9967

23.9967

0.028

decreased

Both of these cell lines are treated with different doses
of carvacrol which are 25 µM, 50 µM, 100 µM, 200 µM
in xCELLigence real-time cell analysis instrument which
measures the proliferation once per 15 min. The results
signify that the proliferation levels of both cell lines
decreased while the concentration level of carvacrol
increased. A previous study points out that a carvacrol
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rich essential oil of origanumacutidens has also significant
anti-proliferative effect against the HT-29 cell line. The
most active concentration of this oil has been found as
100 μg/mL [17]. Moreover, similar to our results, Kai Fana
et al. have studied the antiproliferative effect of carvacrol
on HCT-116 and they detected the IC50 dose as 544.4
µM which is an even higher concentration comparing to
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our result [11]. Even though carvacrol has a significant
antiproliferative effect on both of these cell lines in the
dose-manner, our results indicate that it is more efficient
against HT-29 since IC50 value of HCT-116 doubles the
other line.
The data of proliferation assay on the carvacrol effect
point out that the phyto-compound has a significant role
in both HCT-116 and HT-29 cell lines. However, the
intensity of the cytotoxic responses is different since a more
concentrated dose is required in HCT-116. Considering
this result, the cellular response was evaluated by the
means of secreted soluble factors via multiplexing assay
(Table). The normalized data illuminate that the secretion
of several soluble factors such as prolactin, leptin, and
GM-CSF were increased in carvacrol treated HCT-116
while they were decreased in carvacrol treated HT-29
comparing to nontreated control groups. Considering this
mitogenic effect, survival character was more abundant in
HCT-116 whereas it reduced in HT-29 in response to the
phyto-compound. Therefore, HCT-116 could be evaluated
more resistant and aggressive in carvacrol treatment.
Nevertheless, a significant decrease in proliferative and
survival protein TGF-α and the increase in antigrowth
factors VEGFR2 were correlated with the total cytotoxic
effect in the final response.
The literature mostly confirms the results which
we have obtained in the current study. The sVEGFR2
fragments, transfected to tumor cells, are secreted to the
extracellular matrix and inhibit angiogenesis in vivo [18].
Another soluble factor increased in HCT-116, prolactin
is actively involved in tumorigenesis in several cancers.
The current research also points out that the prolactin
level of HT-29 is dramatically lower compared to the
control group. On the other hand, the level of this factor is
enormously enhanced in the HCT-116 cell line. Moreover,
the scientists investigated in improvement cures to control
tumor growth via reducing the prolactin production [19].
The data introduced in the current study illuminates

the levels of prolactin increased in HCT-116 as a result
of favoring survival and proliferation, whereas it was
decreased in HT-29. Therefore this growth-favored factor
indicates that it is possible to enhance carvacrol treatment.
In addition, the expression level of leptin was measured in
lower levels in the HT-29 cell line compared to its control
group. However, HCT-116 has an elevated level of this
soluble factor. Since, previous reports suggest that leptin
is overexpressed in various types of cancer cells and plays
a role in the development and progression of a variety of
malignancies including colon cancer. Our current study
also reveals another reason why HCT-116 cell line was
more resilient than HT-29 against this compound [20,21].
GM-CSF was another growth factor that decreased in
HT-29 whereas it increased in HCT-116. In addition
to the earlier studies indicating that neutralizing GMCSF reduced the proliferation, angiogenesis, and colonic
epithelial cells (CECs) in neoplasia, our data point out that
this factor is also an accessory after the fact along with
leptin and prolactin [22].
In conclusion, different colorectal cancer cell lines
respond in distinct ways to this phytochemical compound.
On one hand, the antiproliferative feature of carvacrol
has been shown in both cell lines, on the other hand the
HCT-116 response is more resistant to carvacrol treatment
compared to HT-29 cell line. On the basis of present data,
our results revealed that the alteration in levels of soluble
factors in the HCT-116 cell line enhances the ability to
proliferate and survive. Even though some of these factors
slightly favored to tumor growth for HCT-116, carvacrol
affects both cell lines as an antiproliferative agent. Therefore
this study also suggests that some soluble factors could be
drug targets to enhance the effectiveness of carvacrol.
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